CSL charts US plasma manufacturing expansion with $1.5B investment
The company will spend approximately $1.5 billion in capital investments to grow its U.S. plasma-based manufacturing capabilities over the next five years.
Boryung breaks ground on penicillin plant expansion in South Korea
South Korea’s Boryung Corporation continues to boost its production footprint by kicking off a project that will double the capacity of its penicillin manufacturing facility in its home country.
Recall roundup: Fresenius, Sun and Teva among drugmakers pulling products in recent weeks
Since the start of the month, several drug recalls have entered the FDA’s periphery, affecting products ranging from hospital drugs and potassium deficiency injections to antibiotics and a generic medicine for attention-deficit/hyperactivity
Catalent cuts 77 more jobs in Maryland as gene therapy resizing rolls on
Like with the August cuts, the latest round of layoffs will mostly affect the team based in Harmans, Maryland.
AI and Functional Precision Medicine: A Defining Moment for Pediatric Cancer Care
MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Jim Foote, Founder and Chief Executive Officer Jim Foote is the CEO and Co-Founder of First Ascent
PreCheck pulse check: What the industry is saying about FDA’s production initiative
This week on “The Top Line,” we break down what’s known about FDA’s PreCheck, and the parts of the plan that could have the biggest impact on manufacturers.
Cencora earmarks $1B to expand US drug distribution operations
Cencora plans to spend $1 billion over the next five years to expand its operations in the U.S., including opening a second national distribution center in Ohio.
Supernus pauses new patient starts for Parkinson’s pump Onapgo, citing high demand
Some eight months into the launch of Onapgo, the Parkinson’s disease infusion pump Supernus Pharmaceuticals spent years fighting to get across the FDA finish line, the drugmaker is discovering that patients’ appetite
AstraZeneca adds $136M investment to Chinese inhalants plant
AstraZeneca is pouring $136 million more into the expansion of an inhalants production base in China, bringing its total investment at the site to $886 million.
Teva recalls more than half-a-million bottles of blood pressure drug over potential carcinogens
Teva issued a voluntary recall of 580,844 bottles of the widely used blood pressure medication prazosin hydrochloride, citing unacceptable levels of potentially cancer-causing impurities.